Clinical Implications box: Baricitinib seems safe and effective in reducing the articular flares, controlling the systemic inflammation and lung disease progression of COPA patients. The drug dosage should be adjusted according to patient’s age and weight in order to prevent disease flares.
Baricitinib treatment in children with COPA syndrome
Corona, Federica;Pastore, Serena;Tommasini, Alberto;
2024-01-01
Abstract
Clinical Implications box: Baricitinib seems safe and effective in reducing the articular flares, controlling the systemic inflammation and lung disease progression of COPA patients. The drug dosage should be adjusted according to patient’s age and weight in order to prevent disease flares.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Baricitinib treatment in children.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
1.23 MB
Formato
Adobe PDF
|
1.23 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
